Target intelligence / Profile preview

Immune system stimulation via live attenuated Mycobacterium bovis (BCG) (BCG)

Target
BCG
Molecular classification
Live attenuated vaccine, Bacterial vaccine, Immunostimulant
01

Overview

Live attenuated Mycobacterium bovis Bacillus Calmette–Guérin (BCG) is a bacterial vaccine strain primarily used for tuberculosis prevention. It is also recognized for its broad immunostimulatory properties, including the induction of both innate and adaptive immune responses, and has been explored as an immunotherapeutic agent in various infectious diseases, cancer, and autoimmune conditions.

Other names
Bacillus Calmette-GuérinBCG vaccineLive attenuated Mycobacterium bovis
02

Mechanism of action

BCG stimulates innate immunity through interaction with pattern recognition receptors (PRRs), especially toll-like receptors TLR2, TLR4 on dendritic cells and macrophages. It also induces adaptive immunity via antigen presentation and T cell activation, particularly Th1 responses.

03

Biological functions

Immune system stimulationInnate immunity activationAdaptive immunity inductionTrained immunityCytokine productionAntigen presentation
04

Disease associations

Tuberculosis preventionBladder cancer immunotherapyPotential immunotherapy for other infections and cancersAutoimmune disease modulation
05

Safety considerations

Disseminated BCG infection in immunocompromised individualsLocal injection site reactionsFeverRare cases of osteitis or lymphadenitis
06

Interacting drugs

None (BCG is a vaccine, not a drug)

1 more in the full profile.

07

Biomarkers

IFN-γ productionT cell proliferationAntibody titersExpression of activation markers on immune cells (e.g., CD69, CD25)

Beyond the preview

Go deeper on Immune system stimulation via live attenuated Mycobacterium bovis (BCG) (BCG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system stimulation via live attenuated Mycobacterium bovis (BCG) (BCG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call